⌘K

Home/Filings/4/0000908662-15-000079

4//SEC Filing

ENANTA PHARMACEUTICALS INC 4

Accession 0000908662-15-000079

$ENTACIK 0001177648operating

View on SEC.gov Company Profile

Filed

Feb 19, 7:00 PM ET

Accepted

Feb 20, 4:24 PM ET

Size

5.4 KB

Accession

0000908662-15-000079

Insider Transaction Report

Form 4

Period: 2015-02-19

ENANTA PHARMACEUTICALS INCENTA

AFTING ERNST-GUNTER

Director

Transactions

Award
Stock Option (right to buy)
2015-02-19+6,000→ 6,000 total
Exercise: $33.65Exp: 2025-02-19→ Common Stock (6,000 underlying)

Footnotes (1)

[F1]Such option will become exercisable monthly in substantially equal installments over one year, beginning from the date of grant (February 19, 2015), with the final monthly installment vesting at the 2016 annual meeting of stockholders.

Documents

1 file

4
edgar.xmlPrimary
PRIMARY DOCUMENT

Issuer

ENANTA PHARMACEUTICALS INC

CIK 0001177648

Entity typeoperating

Related Parties

1

filerCIK 0001177648

Filing Metadata

Form type: 4
Filed: Feb 19, 7:00 PM ET
Accepted: Feb 20, 4:24 PM ET
Size: 5.4 KB

View on SEC.gov